NCT00918398 - AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions

HealthyPostmenopausalSurgically Sterile Women

Interventions

DRUG

AZD1981

100 mg iv infusion, single dose, 4 hours infusion

DRUG

AZD1981

514 mg oral solution, single dose

DRUG

AZD1981

500 mg oral tablet A (optimal dissolution) give as 2x250 mg tablets, single dose

DRUG

AZD1981

500 mg oral tablet B (slower dissolution) give as 2x250 mg tablets, single dose

Trial Locations (1)

Research Site, Uppsala